Successful Treatment of Warm Autoimmune Hemolytic Anemia with a Positive Donath-Landsteiner Test Using Rituximab

被引：1
|
作者：
Hiranuma, Naoko [1 ]
Koba, Yusuke [1 ]
Kawata, Takahito [1 ,2 ]
Tamekane, Akira [1 ]
Watanabe, Mitsumasa [1 ]
机构：
[1] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Hematol, Amagasaki, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan
来源：
INTERNAL MEDICINE | 2024年 / 63卷 / 15期
关键词：
autoimmune hemolytic anemia; blood transfusion; Donath-Landsteiner antibody test; paroxysmal cold hemoglobinuria; rituximab;
D O I：
10.2169/internalmedicine.2088-23
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Paroxysmal cold hemoglobinuria (PCH) is a rare disease in adults, and its concurrent presentation with warm-type autoimmune hemolytic anemia (AIHA) has not yet been reported. We encountered a 19-year-old woman with AIHA and a positive Donath-Landsteiner test result identified by a hemolytic attack during blood transfusion. She also showed positive results for the direct Coombs and Donath-Landsteiner antibody tests. After treatment with prednisolone followed by rituximab, the AIHA improved, and the DonathLandsteiner antibody test result turned negative. Clinicians should be aware that patients may present with concurrent warm-type AIHA and PCH and consider rituximab for its treatment.
引用
收藏
页码：2173 / 2176
页数：4
相关论文
共 50 条
  • [31] Successful Treatment of Autoimmune Hemolytic Anemia Due to IgA and IgG Warm Autoantibodies
    Reyes, M. A.
    Margolin, J.
    Mahoney, D. H.
    Garratty, G.
    Teruya, J.
    TRANSFUSION, 2009, 49 : 202A - 202A
  • [32] Bortezomib and rituximab in multiply relapsed primary warm autoimmune hemolytic anemia
    Ames, Paul R. J.
    Jeffrey, Susan
    ANNALS OF HEMATOLOGY, 2021, 100 (09) : 2415 - 2416
  • [33] Bortezomib and rituximab in multiply relapsed primary warm autoimmune hemolytic anemia
    Paul R. J. Ames
    Susan Jeffrey
    Annals of Hematology, 2021, 100 : 2415 - 2416
  • [34] The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia
    Pamuk, Gulsum Emel
    Turgut, Burhan
    Demir, Muzaffer
    Tezcan, Fatma
    Vural, Ozden
    AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (08) : 631 - 633
  • [35] Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab
    Ramanathan, S
    Koutts, J
    Hertzberg, MS
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (02) : 123 - 126
  • [36] THE TREATMENT OF REFRACTORY FORM AUTOIMMUNE HEMOLYTIC ANEMIA BY RITUXIMAB
    Tsvetaeva, N.
    Nikulina, F.
    Gretsov, M.
    Garanga, A.
    Ghuravlev, S.
    Khoroshko, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 709 - 709
  • [37] Rituximab for the treatment of refractory autoimmune hemolytic anemia in children
    Zecca, M
    Nobili, B
    Ramenghi, U
    Perrotta, S
    Amendola, G
    Rosito, P
    Jankovic, M
    Pierani, P
    De Stefano, P
    Bonora, MR
    Locatelli, F
    BLOOD, 2003, 101 (10) : 3857 - 3861
  • [38] New Therapies for the Treatment of Warm Autoimmune Hemolytic Anemia
    Fattizzo, Bruno
    Barcellini, Wilma
    TRANSFUSION MEDICINE REVIEWS, 2022, 36 (04) : 175 - 180
  • [39] Warm autoimmune hemolytic anemia and the best treatment strategies
    Kuter, David J.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2022, (01) : 105 - 113
  • [40] A case report of refractory warm autoimmune hemolytic anemia treated with plasmapheresis and rituximab
    Aglieco, Fabio
    Manickaratnam, Srimathi
    Bona, Robert
    Kaplan, Andre A.
    THERAPEUTIC APHERESIS AND DIALYSIS, 2008, 12 (02) : 185 - 189
12345